Medidata Solutions, Inc. 4

4 · Medidata Solutions, Inc. · Filed Feb 11, 2015

Form 4

Period: 2015-02-10

Director

Transactions

Exercise/Conversion
Common Stock
2015-02-10$14.00/sh+11,820$165,480→ 67,610 total
Exercise/Conversion
Common Stock
2015-02-10$15.35/sh+5,924$90,933→ 73,534 total
Exercise/Conversion
Common Stock
2015-02-10$27.97/sh+5,214$145,836→ 78,748 total
Exercise/Conversion
Common Stock
2015-02-10$11.49/sh+5,714$65,682→ 84,462 total
Sale
Common Stock
2015-02-10$44.07/sh−28,672$1,263,638→ 55,790 total
Exercise/Conversion
Stock Option (right to buy)
2015-02-10−11,820→ 11,820 total
Exercise: $14.00Exp: 2019-06-24→ Common Stock (23,640 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-02-10−5,924→ 0 total
Exercise: $15.35Exp: 2020-05-18→ Common Stock (5,924 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-02-10−5,214→ 0 total
Exercise: $27.97Exp: 2022-05-16→ Common Stock (5,214 underlying)
Exercise/Conversion
Stock Option (right to buy)
2015-02-10−5,714→ 0 total
Exercise: $22.99Exp: 2021-05-21→ Common Stock (5,714 underlying)

Footnotes (3)

[F1]Such transaction was executed in multiple trades at prices ranging from $44.00 to $44.14. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
[F2]These options vest in 24 equal monthly installments commencing one month after the grant date, subject to continued employment.
[F3]The total number of shares beneficially owned by the reporting person has been adjusted to reflect the Company's two-for-one stock split, which became effective on December 16, 2013.

Documents

1 file